Trademark Search in Canada

REGAIN CONTROL: SIRS AND SEPSIS

View On IC.GC.CA

REGISTERED

on 27 Oct 2022

Last Applicant/ Owned by

CYTOSORBENTS CORPORATION

7 Deer Park DriveCity of Monmouth Junction, NJ 08852

Serial Number

1935945 filed on 13^th Dec 2018

Registration Number

TMA1148331 registered on 27^th Oct 2022

Registration expiry Date

27^th Oct 2032

Correspondent Address

BCF S.E.N.C.R.L./BCF LLP

1100, boul. René-Lévesque Ouest25e ÉtageMontréal

QUÉBEC

H3B5C9

REGAIN CONTROL: SIRS AND SEPSIS

Trademark usage description

medical devices, namely, extracorporeal cytokine adsorber for treating the blood of patients who are at risk of or who have medically destabilizing co Read More

Classification Information

Class [010]
Medical devices, namely, extracorporeal cytokine adsorber for treating the blood of patients who are at risk of or who have medically destabilizing conditions such as the systemic inflammatory response syndrome, sepsis, infection, organ dysfunction and failure.

Classification kind code

Mark Details

Serial Number

1935945

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 12^th Oct 2022	Registration Pending
Submitted for opposition 191 on 12^th Oct 2022	Registration Fee Notice Sent
Submitted for opposition 42 on 20^th Jul 2022	Advertised
Submitted for opposition 26 on 25^th May 2022	Approved
Submitted for opposition 27 on 25^th May 2022	Approval Notice Sent
Submitted for opposition 22 on 5^th Oct 2021	Search Recorded
Submitted for opposition 20 on 5^th Oct 2021	Examiner's First Report
Submitted for opposition 31 on 24^th Dec 2018	Formalized
Submitted for opposition 1 on 14^th Dec 2018	Created
Submitted for opposition 30 on 13^th Dec 2018	Filed

REGAIN CONTROL: SIRS AND SEPSIS

Classification Information

Class [010]Medical devices, namely, extracorporeal cytokine adsorber for treating the blood of patients who are at risk of or who have medically destabilizing conditions such as the systemic inflammatory response syndrome, sepsis, infection, organ dysfunction and failure.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [010]
Medical devices, namely, extracorporeal cytokine adsorber for treating the blood of patients who are at risk of or who have medically destabilizing conditions such as the systemic inflammatory response syndrome, sepsis, infection, organ dysfunction and failure.